Author

Champagne C

Fordham University - Cited by 2,077 - Cost-Benefit Analysis - Health Economics - Public Finance

Biography

Champagne C is from University of Rochester , USA. Recently he published an article in the Journal of Glycomics and Lipidomics.Champagne C is from University of Rochester , USA. Recently he published an article in the Journal of Glycomics and Lipidomics.
Title
Cited by
Year
The Value of Reducing HIV Stigma
RJ BrentSocial Science and Medicine 151 (January), 233-240, 2016201
57
2016
The value of reducing HIV stigma
RJ BrentSocial Science & Medicine 151, 233-240, 2016201
57
2016
An implicit price of a DALY for use in a cost-benefit analysis of ARVs
RJ BrentApplied Economics 43 (11), 1413-1421, 2011201
39
2011
A cost-benefit analysis of female primary education as a means of reducing HIV/AIDS in Tanzania
RJ BrentApplied Economics 41 (14), 1731-1743, 2009200
35
2009
Advanced introduction to cost–benefit analysis
RJ BrentEdward Elgar Publishing, 2017201
25
2017
Setting priorities for HIV/AIDS interventions: A cost-benefit approach
RJ BrentEdward Elgar Publishing, 2010201
18
2010
The effects of HIV medications on the quality of life of older adults in New York City
RJ BrentHealth economics 21 (8), 967-976, 2012201
18
2012
The effects of HIV medications on the quality of life of older adults in New York City
RJ BrentHealth economics 21 (8), 967-976, 2012201
18
2012
A cost–benefit analysis of hearing aids, including the benefits of reducing the symptoms of dementia
RJ BrentApplied economics 51 (28), 3091-3103, 2019201
18
2019
A social cost–benefit criterion for evaluating voluntary counseling and testing with an application to Tanzania
RJ BrentHealth Economics 19 (2), 154-2, 2010201
17
2010
A cost-benefit framework for evaluating conditional cash-transfer programs
RJ BrentJournal of Benefit-Cost Analysis 4 (2), 9-180, 2013201
15
2013
Economic evaluations of HIV prevention in rich countries and the need to focus on the aging of the HIV-positive population
RJ Brent, M Brennan, SE KarpiakCurrent Opinion in HIV and AIDS 5 (3), 255-260, 2010201
11
2010
The value of a year’s general education for reducing the symptoms of dementia
RJ BrentApplied Economics 50 (25), 2812-2823, 2018201
10
2018
Behavioral versus biological definitions of dementia symptoms: recognizing that worthwhile interventions already exist
RJ BrentOBM geriatrics 3 (4), 2019201
10
2019
Life expectancy in nursing homes
RJ BrentApplied Economics 54 (16), 177-1, 2022202
8
2022
The economic value of reducing the stigma of HIV/AIDS
RJ BrentExpert Review of Pharmacoeconomics & Outcomes Research 13 (5), 561-563, 2013201
7
2013
Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia
RJ BrentApplied economics 50 (58), 327-340, 2018201
6
2018
Valuing the prevention of elder abuse
RJ BrentApplied Economics 47 (58), 32-373, 2015201
6
2015
Why countries have both subsidized and free condoms to prevent HIV/AIDS: The role of stigma mitigation
RJ BrentJournal of African Development 12 (2), 61-72, 2010201
5
2010
Using a Happiness Index to Measure the Benefits for a Cost Benefit Analysis of Antiretrovirals for Older Adults with HIV in New York City
RJ Brent, M Brennan, SE KarpiakAIDS 1 (2), 1009, 2018201
4
2018

Referred From: https://scholar.google.com/citations?user=VQk0lS8AAAAJ&hl=en

Cited by
Citations 2077
h-index 17
i10-index 30
Recommended Journals
Open Access Journals